• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Paymentus Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

    3/5/24 8:06:27 AM ET
    $AIMD
    $AVAV
    $CARA
    $CJJD
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Aerospace
    Industrials
    Get the next $AIMD alert in real time by email

    Shares of Paymentus Holdings, Inc. (NYSE:PAY) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth quarter financial results.

    Paymentus reported quarterly earnings of 11 cents per share which beat the analyst consensus estimate of 7 cents per share. Quarterly sales clocked in at $164.8 million which beat the analyst consensus estimate of $157.416 million.

    Paymentus Holdings shares jumped 18.3% to $19.34 in pre-market trading

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Zhongchao Inc. (NASDAQ:ZCMD) gained 79.8% to $5.70 in pre-market trading. Zhongchao recently announced a 1-for-10 share consolidation.
    • Momentus Inc. (NASDAQ:MNTS) shares rose 46.2% to $1.14 in pre-market trading after the company was awarded a contract from NASA.
    • Phunware, Inc. (NASDAQ:PHUN) shares rose 30.2% to $16.16 in pre-market trading. Phunware shares jumped 75% on Monday amid volatility in Trump-related stocks after Donald Trump won the Missouri and Idaho Republican caucuses. Also, the Supreme Court ruled that Colorado can't remove Donald Trump from the Republican primary ballot in the state.
    • Sunshine Biopharma, Inc. (NASDAQ:SBFM) gained 19.3% to $0.0536 in pre-market trading after dipping 19% on Monday. Sunshine Biopharma recently announced closing of $10.0 million underwritten public offering.
    • AeroVironment, Inc. (NASDAQ:AVAV) shares surged 19.1% to $155.50 in pre-market trading after the company reported better-than-expected results for its fourth quarter. The company said it sees FY24 adjusted earnings of $2.69 to $2.83 per share on revenue of $700 million to $710 million.
    • Vicarious Surgical Inc. (NYSE:RBOT) rose 15.2% to $0.4149 in pre-market trading after the company reported quarterly financial results.
    • NKGen Biotech, Inc. (NASDAQ:NKGN) climbed 13.5% to $0.9480 in pre-market trading. NKGen Biotech will present data on SNK01 in Alzheimer's disease at the Tau2024 Global Conference Mar. 25-26.
    • China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) shares gained 12.8% to $3.00 in pre-market trading after declining 9% on Monday. China Jo-Jo Drugstores recently announced a 1-for-20 reverse stock split.
    • New York Community Bancorp, Inc. (NASDAQ:NYCB) gained 6.3% to $2.90 in pre-market trading after falling 23% on Monday. New York Community Bancorp last week announced that it identified material weaknesses in its internal controls and replaced its CEO.

    Losers

    • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) fell 28.3% to $2.08 in pre-market trading. Quoin Pharmaceuticals shares gained over 3% on Monday after the company announced FDA clearance to recruit teen subjects into both of its ongoing Netherton Syndrome clinical studies.
    • GitLab Inc. (NASDAQ:GTLB) shares tumbled 22.4% to $57.80 after the company issued FY25 earnings guidance below estimates.
    • Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) fell 17.6% to $1.73 pre-market trading after the company reported mixed fourth-quarter financial results.
    • Cara Therapeutics, Inc. (NASDAQ:CARA) fell 16.7% to $0.8325 in pre-market trading following downbeat fourth-quarter results.
    • Renalytix Plc (NASDAQ:RNLX) shares declined 15% to $1.25 in pre-market trading. Renalytix shares jumped 41% on Monday after the company announced that it received an unsolicited approach from a publicly listed strategic diagnostics company.
    • Stitch Fix, Inc. (NASDAQ:SFIX) shares dipped 14.5% to $2.80 in pre-market trading after the company reported worse-than-expected second-quarter financial results and issued a weak revenue forecast for FY24.
    • Ainos, Inc. (NASDAQ:AIMD) shares fell 12.5% to $1.24 in pre-market trading after surging 35% on Monday.
    • Vivakor, Inc. (NASDAQ:VIVK) shares fell 11.4% to $0.9397 in pre-market trading after jumping around 30% on Monday. Vivakor signed a definitive merger agreement with Empire Diversified Energy for a combined enterprise value of approximately $250 million.
    • Ethereal Tech PTE. Ltd (NASDAQ:FUFU) shares declined 11.4% to $11.62 in pre-market trading. BitFuFu shares jumped around 106% on Monday amid volatility following the company's recent business combination with Arisz Acquisition Corp and listing on the Nasdaq.
    • MingZhu Logistics Holdings Limited (NASDAQ:YGMZ) shares fell 10.9% to $0.48 in pre-market trading after gaining over 12% on Monday. MingZhu Logistics Holdings signed a non-binding letter of intent (LOI) to acquire driverless auto technologies and intellectual property (IP) portfolio valued between $80 million and $90 million.

     

    Now Read This: Stitch Fix, Target And 3 Stocks To Watch Heading Into Tuesday

    Get the next $AIMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIMD
    $AVAV
    $CARA
    $CJJD

    CompanyDatePrice TargetRatingAnalyst
    GitLab Inc.
    $GTLB
    3/4/2026$28.00Overweight → Neutral
    Piper Sandler
    AeroVironment Inc.
    $AVAV
    3/2/2026Strong Buy → Underperform
    Raymond James
    AeroVironment Inc.
    $AVAV
    3/2/2026Strong Buy → Outperform
    Raymond James
    GitLab Inc.
    $GTLB
    3/2/2026$29.00Buy → Hold
    TD Cowen
    Paymentus Holdings Inc.
    $PAY
    2/20/2026$35.00Outperform → Strong Buy
    Raymond James
    AeroVironment Inc.
    $AVAV
    2/18/2026$259.00Neutral
    UBS
    AeroVironment Inc.
    $AVAV
    2/17/2026$320.00Overweight
    Analyst
    GitLab Inc.
    $GTLB
    1/12/2026$34.00Equal Weight → Underweight
    Barclays
    More analyst ratings

    $AIMD
    $AVAV
    $CARA
    $CJJD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIMD
    $AVAV
    $CARA
    $CJJD
    SEC Filings

    View All

    AeroVironment Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - AeroVironment Inc (0001368622) (Filer)

    3/10/26 4:13:50 PM ET
    $AVAV
    Aerospace
    Industrials

    Vicarious Surgical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - Vicarious Surgical Inc. (0001812173) (Filer)

    3/9/26 4:17:50 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    SEC Form 10-K filed by Vicarious Surgical Inc.

    10-K - Vicarious Surgical Inc. (0001812173) (Filer)

    3/9/26 4:16:00 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    $AIMD
    $AVAV
    $CARA
    $CJJD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GitLab downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded GitLab from Overweight to Neutral and set a new price target of $28.00

    3/4/26 8:35:56 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    AeroVironment downgraded by Raymond James

    Raymond James downgraded AeroVironment from Strong Buy to Underperform

    3/2/26 10:47:34 AM ET
    $AVAV
    Aerospace
    Industrials

    AeroVironment downgraded by Raymond James

    Raymond James downgraded AeroVironment from Strong Buy to Outperform

    3/2/26 10:46:25 AM ET
    $AVAV
    Aerospace
    Industrials

    $AIMD
    $AVAV
    $CARA
    $CJJD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Technology Officer Schwarz Robert E

    4 - Momentus Inc. (0001781162) (Issuer)

    3/3/26 6:58:28 PM ET
    $MNTS
    Military/Government/Technical
    Industrials

    SEC Form 4 filed by Chief Legal Officer Layman Jon

    4 - Momentus Inc. (0001781162) (Issuer)

    3/3/26 6:52:10 PM ET
    $MNTS
    Military/Government/Technical
    Industrials

    SEC Form 4 filed by Chief Financial Officer Ensler Lon

    4 - Momentus Inc. (0001781162) (Issuer)

    3/3/26 6:41:33 PM ET
    $MNTS
    Military/Government/Technical
    Industrials

    $AIMD
    $AVAV
    $CARA
    $CJJD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Asher Daniel bought $191,162 worth of shares (15,540 units at $12.30) (SEC Form 4)

    4 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)

    2/20/26 4:57:37 PM ET
    $EKSO
    Industrial Machinery/Components
    Industrials

    Large owner Asher Daniel bought $11,520 worth of shares (1,200 units at $9.60) (SEC Form 4)

    4 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)

    2/19/26 4:03:47 PM ET
    $EKSO
    Industrial Machinery/Components
    Industrials

    Large owner Asher Daniel bought $970,069 worth of shares (102,029 units at $9.51) (SEC Form 4)

    4 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)

    2/17/26 3:42:24 PM ET
    $EKSO
    Industrial Machinery/Components
    Industrials

    $AIMD
    $AVAV
    $CARA
    $CJJD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AeroVironment Announces Fiscal 2026 Third Quarter Results

    AeroVironment, Inc. (NASDAQ:AVAV) ("AeroVironment" or the "Company") reported today financial results for the fiscal third quarter ended January 31, 2026. Third Quarter Highlights: Third quarter revenue of $408.0 million Bookings of $2.1 billion and book-to-bill ratio of 1.6 for the first nine months of the fiscal year Record funded backlog of $1.1 billion "While our third quarter results were impacted by revenue timing and adjustments in our Space business, demand for our unique solutions remains robust," said Wahid Nawabi, AeroVironment chairman, president and chief executive officer. "Strong order flow and growth in funded backlog during the quarter are setting the stage fo

    3/10/26 4:10:00 PM ET
    $AVAV
    Aerospace
    Industrials

    NKGen Biotech to Present Integrated Phase 1 Clinical and Biomarker Analyses for Troculeucel in Alzheimer's Disease at AD/PD™ 2026

    SANTA ANA, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC:NKGN) ("NKGen" or the "Company"), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer ("NK") cell therapeutics, today announced upcoming oral and poster presentations at the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders ("AD/PD™ 2026"), taking place March 17-21, 2026, in Copenhagen, Denmark and virtually. The presentations will highlight a new integrated analysis of patient-level data from two previously completed Phase 1 studies evaluating troculeucel in patients with

    3/10/26 8:05:00 AM ET
    $NKGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    From the Tarmac to the Stars: Defense Budgets Fueling the Next Aerospace Boom

    CAPE CANAVERAL, Fla., March 06, 2026 (GLOBE NEWSWIRE) -- USA News Group News Commentary — The U.S. Space Force secured a nearly $14 billion boost to its budget in fiscal 2026, bringing its total allocation to approximately $40 billion, more than double its first independent budget of $15 billion in fiscal 2021[1]. The administration has proposed increasing total annual military spending to $1.5 trillion by fiscal 2027, with specific focus on the Golden Dome proliferated space-based defense architecture and proliferated satellite constellations[2]. Companies positioned across aerospace testing, defense manufacturing, and space infrastructure include Starfighters Space (NYSE-A: FJET), AeroVi

    3/6/26 9:00:00 AM ET
    $ACHR
    $AVAV
    $CW
    Aerospace
    Industrials
    Industrial Machinery/Components
    Technology

    $AIMD
    $AVAV
    $CARA
    $CJJD
    Leadership Updates

    Live Leadership Updates

    View All

    AV Announces Retirement of Chief Financial Officer Kevin McDonnell

    AeroVironment, Inc. ("AV" or the "Company") (NASDAQ:AVAV), a global defense technology leader, today announced that Kevin McDonnell, Executive Vice President and Chief Financial Officer, has informed the Company of his decision to retire from AV, effective July 31, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260223105811/en/McDonnell joined AV in 2020. During his tenure as CFO, AV strengthened its balance sheet, enhanced its financial and operational discipline, completed strategic acquisitions and organic growth initiatives, and reinforced its capital allocation framework to drive long-term shareholder value. "Kevin ha

    2/23/26 5:13:00 PM ET
    $AVAV
    Aerospace
    Industrials

    AV Welcomes Stephen Voline as Senior Director, Washington Operations

    Experienced defense policy and government relations leader brings decades of military, legislative, and industry expertise to AV's Washington Operations team AeroVironment, Inc. ("AV") (NASDAQ:AVAV), a global defense technology leader, today announced that Stephen Voline has joined the company as Senior Director of Washington Operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211855975/en/Stephen Voline brings more than three decades of experience across military operations, defense policy, and industry advocacy. Voline will support AV's engagement with Congress, the Department of War, and key national security stak

    2/11/26 7:30:00 AM ET
    $AVAV
    Aerospace
    Industrials

    NKGen Biotech Names Leading Dementia Expert Bruce L. Miller, M.D. to Scientific Advisory Board

    SANTA ANA, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC:NKGN) ("NKGen" or the "Company"), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer ("NK") cell therapeutics, today announced the appointment of Bruce L. Miller, M.D. to its Scientific Advisory Board. Dr. Miller is internationally recognized for his leadership in Alzheimer's disease ("AD"), frontotemporal dementia ("FTD"), and other neurocognitive disorders, and brings extensive scientific and clinical expertise to the Company. Dr. Miller is the A.W. and Mary Margaret Clausen Distinguished Professor in Neurology at the U

    1/22/26 8:05:00 AM ET
    $NKGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AIMD
    $AVAV
    $CARA
    $CJJD
    Financials

    Live finance-specific insights

    View All

    AeroVironment Announces Fiscal 2026 Third Quarter Results

    AeroVironment, Inc. (NASDAQ:AVAV) ("AeroVironment" or the "Company") reported today financial results for the fiscal third quarter ended January 31, 2026. Third Quarter Highlights: Third quarter revenue of $408.0 million Bookings of $2.1 billion and book-to-bill ratio of 1.6 for the first nine months of the fiscal year Record funded backlog of $1.1 billion "While our third quarter results were impacted by revenue timing and adjustments in our Space business, demand for our unique solutions remains robust," said Wahid Nawabi, AeroVironment chairman, president and chief executive officer. "Strong order flow and growth in funded backlog during the quarter are setting the stage fo

    3/10/26 4:10:00 PM ET
    $AVAV
    Aerospace
    Industrials

    Vicarious Surgical Receives Delisting Notice From NYSE

    Vicarious Surgical Inc. (NYSE:RBOT) (the "Company"), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced that on March 3, 2026, it received a notice (the "Notice") from the New York Stock Exchange (the "NYSE") that the NYSE has commenced the process of delisting the Company's Class A common stock, par value $0.0001 per share (the "Common Stock"). Trading on the Company's Common Stock on the NYSE was suspended after market close on March 3, 2026. The NYSE has determined that the Company has fallen below the continued listing standard, requiring listed companies to maintain an average global market capitalization over a con

    3/4/26 7:00:00 AM ET
    $RBOT
    Industrial Specialties
    Health Care

    GitLab Reports Fourth Quarter and Full Year Fiscal Year 2026 Financial Results; Board of Directors Authorizes $400 million for Share Repurchase Program

    Fourth Quarter Fiscal Year 2026 Highlights: Total revenue of $260.4 million, up 23% year-over-year GAAP operating margin of (2)%; non-GAAP operating margin of 21% Operating cash flow of $45.8 million and non-GAAP adjusted free cash flow of $41.8 million Fiscal Year 2026 Highlights: Total revenue of $955.2 million, up 26% year-over-year GAAP operating margin of (7)%; non-GAAP operating margin of 17% Operating cash flow of $232.9 million and non-GAAP adjusted free cash flow of $219.6 million -All-Remote-GitLab Inc. (NASDAQ:GTLB), the intelligent orchestration platform for DevSecOps, today reported financial results for its fourth quarter fiscal year of 2026, ended Janu

    3/3/26 4:05:00 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    $AIMD
    $AVAV
    $CARA
    $CJJD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Paymentus Holdings Inc.

    SC 13G - Paymentus Holdings, Inc. (0001841156) (Subject)

    12/10/24 5:08:45 PM ET
    $PAY
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Ainos Inc.

    SC 13D/A - Ainos, Inc. (0001014763) (Subject)

    11/27/24 6:08:44 AM ET
    $AIMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Quoin Pharmaceuticals Ltd.

    SC 13G/A - Quoin Pharmaceuticals, Ltd. (0001671502) (Subject)

    11/14/24 7:23:29 PM ET
    $QNRX
    Medical/Dental Instruments
    Health Care